Why knee cartilage cannot repair itself

The short answer to 'will this settle on its own?' is no — and the reason is built into the tissue itself.

Articular cartilage is the smooth, glassy lining that covers the ends of the bones inside your knee joint. Unlike most tissues in the body, it contains no blood vessels and no nerve fibres. That absence of a blood supply is the central problem: blood is how the body delivers the repair cells and signalling molecules that heal a cut or a fractured bone. Without it, cartilage has no biological mechanism to patch a damaged area. Experimental studies confirm this — full-thickness chondral defects show no evidence of spontaneous healing unless the bone beneath them is breached.

This means a focal cartilage defect does not reach an equilibrium and stay there. Under the normal loads of walking and stair-climbing, the damaged edges continue to break down and the defect tends to expand.

Clinicians describe the depth of cartilage damage using the ICRS grading system, which runs from Grade 1 (surface softening) through to Grade 4 (a hole reaching through the cartilage column into the subchondral bone beneath). Grade matters clinically because the depth of damage determines how much healthy tissue remains — and therefore which repair options are still available. The deeper the lesion at the point of assessment, the narrower that menu becomes.

The degeneration cascade — what actually happens inside the knee

Once a focal defect forms, the joint does not simply 'wear' at a steady pace — it moves through a sequence of escalating changes, each stage making the next harder to reverse.

Stage 1 — boundary expansion under load. Every step transfers force across the knee. Where the cartilage surface is intact, that load spreads evenly. Where there is a gap or softened area, stress concentrates at the defect margins. The damaged edges fray further with each loading cycle, and the lesion boundary creeps outward. Beneath the thinning cartilage, the subchondral bone — the dense bony layer that normally acts as a shock-absorbing foundation — begins to bear direct stress it is not built to handle.

Stage 2 — bone remodelling and early structural change. Sustained abnormal loading causes the exposed bone to remodel: it becomes denser and stiffer (sclerosis), loses its capacity to absorb impact, and, over time, develops bony outgrowths (osteophytes) at the joint margins. Critically, this is where the subchondral bone shifts from victim to driver. Pathological changes within it — including inflammatory bone marrow lesions detectable on MRI — actively accelerate the breakdown of the cartilage above, creating a self-reinforcing cycle of damage.

Stage 3 — joint-wide inflammation. As cartilage matrix fragments break off into the joint space, the synovial lining (the membrane that produces joint fluid) responds with inflammation. This inflamed environment degrades adjacent healthy cartilage that was not part of the original injury — the damage is no longer focal.

Stage 4 — multi-compartment deterioration and bone-on-bone contact. Joint-space narrowing spreads across compartments, cartilage coverage becomes patchy, and eventually the bone ends move against each other — the structural definition of end-stage osteoarthritis.

Lesion depth substantially influences how quickly this sequence unfolds. Superficial Grade 1–2 lesions, involving less than 50% of the cartilage column, may progress slowly in some patients, particularly those who are younger, well-aligned, and of healthy weight. Grade 3–4 lesions — extending beyond half the cartilage depth or through the subchondral plate — advance to later stages considerably faster. This is why the stage at which someone seeks assessment directly determines which interventions are still on the table.

How fast the repair window closes — what the evidence shows

The clearest evidence of how quickly that window narrows comes from a 2021 retrospective study of 111 patients waiting for ACI or MACI implantation. During the interval between diagnosis and surgery, the primary cartilage defect expanded by roughly 0.11 cm² for every month of delay — an adjusted figure of 0.15 cm² per month when other variables were accounted for. More strikingly, 16.2% of those patients — approximately one in six — developed a new area of high-grade damage in that time, not from a fresh fall or new injury, but simply from waiting. Each additional month on the waiting list raised the odds of a new high-grade secondary lesion by around 21% (adjusted OR 1.21, 95% CI 1.01–1.44; p=0.036). In practical terms, a defect that was borderline for a less invasive procedure at the time of diagnosis may have crossed the size threshold into more complex surgery by the time the operation was scheduled.

Longer-term data from a 12-year follow-up of patients with osteochondritis dissecans of the knee reinforces this picture. At initial assessment, 90% had minimal radiological change (Kellgren–Lawrence grades 0–1). By 12-year follow-up, 45% had shown measurable radiological OA progression, with lesion depth (p=0.0007), higher BMI (p=0.004), and older age at diagnosis (p=0.003) as independent predictors. The 55% who avoided progression tended to be younger and have shallower lesions when first assessed — a finding that argues for early evaluation rather than a message of reassurance, since the non-progressors' advantage was established at baseline, not acquired later.

Both studies draw on patients who had already come to surgical attention, so the figures likely reflect a more symptomatic population than average. Genuinely untreated controls cannot ethically be randomised and left unmanaged, which means the numbers should be read as illustrative of direction and magnitude rather than as universal rates. Even with that qualification folded in, the data point consistently the same way: the repair window does not hold steady while a decision is being made — it actively closes, month by month.

Factors that speed up cartilage loss

Not every knee with the same ICRS grade deteriorates at the same speed. Several co-pathologies concentrate mechanical stress on an already-damaged area, narrowing the repair window faster than the baseline figures suggest.

ACL deficiency. An intact anterior cruciate ligament stabilises the tibia against the femur during movement. When it is torn and left unaddressed, the knee translates abnormally on each step, redistributing load onto cartilage surfaces not positioned to accept it — accelerating focal lesion expansion beyond what body weight alone would produce.

Meniscal loss or extrusion. The menisci absorb and spread compressive force across the tibiofemoral compartment. Once a meniscus is torn, extruded, or removed, that load-distributing function is lost, and stress falls directly onto the articular cartilage — a pattern strongly linked to bone marrow lesions, cartilage wear, and early OA. Among patients with medial meniscal posterior root tears, 39% showed worsening chondral grade after a mean of just 3.5 months without intervention.

Coronal malalignment. Varus or valgus alignment channels the mechanical axis preferentially through one compartment, compounding the stress on any lesion that lies within it. Where malalignment is a contributing factor, a corrective osteotomy — high tibial (HTO) for medial-compartment overloading, or distal femoral (DFO) for lateral — can offload the affected area and is sometimes combined with or performed before cartilage restoration.

Higher BMI. Greater body weight amplifies compressive forces across the joint on every loading cycle, adding to the stress already concentrated at defect margins. The long-term cohort evidence described in the previous section confirms BMI as an independent accelerant of radiological progression — and its effect is additive to the mechanical factors above, not separate from them.

Together, these explain why two patients presenting with equivalent-grade lesions can follow markedly different trajectories. A clinician evaluating a new presentation will assess all four at the outset.

How delay changes which treatments are still possible

The practical consequence of waiting is not just more pain — it is a shrinking list of procedures that can plausibly work.

Defect size is the primary gating factor in cartilage repair planning. Think of it as a ladder: the smaller the lesion, the less invasive the options. A focal defect of around 1–2 cm² may be suitable for autograft transfer (OATS/mosaicplasty), where a plug of healthy bone and cartilage is relocated from a low-load area to fill the gap, or for a ChondroFiller injection — an ultrasound-guided outpatient procedure that places an injectable collagen scaffold into the defect, recruiting the patient's own progenitor cells. As area climbs toward and above 2–3 cm², the bar rises: the cell-based and matrix techniques become appropriate — autologous chondrocyte implantation (ACI), its matrix-based variant (MACI), and autologous matrix-induced chondrogenesis (AMIC, which combines marrow stimulation with a protective membrane scaffold). For very large or post-traumatic defects, an osteochondral allograft (OCA) — transplanting donor tissue including its bone base — may be the only realistic restoration option short of replacement.

The SUMMIT trial provides direct evidence of what happens when procedure choice is mismatched to defect size: for lesions above approximately 3 cm², MACI delivered significantly better pain and function scores than microfracture at both two and five years. That gap matters in practice, because month-by-month lesion growth can push a patient from the OATS or ChondroFiller bracket into the MACI or ACI range, and eventually into OCA territory.

Microfracture warrants a specific caution beyond its modest long-term track record. The procedure carries a real risk of damaging the subchondral bone plate — the biological substrate that cell-based techniques depend on. A failed microfracture can therefore reduce the viability of any subsequent, more sophisticated repair.

Once damage becomes diffuse across multiple compartments, cartilage preservation is no longer a realistic goal and the conversation appropriately shifts to joint replacement. For anyone with a confirmed focal defect, the practical message is concrete: prompt assessment keeps the simpler, lower-morbidity options available — and each month of delay edges the decision further up the ladder.

When to seek assessment and what it involves

Pain on stairs that returns after each activity session, a catching or locking sensation during everyday movement, swelling that takes more than 48 hours to settle, or persistent stiffness that does not resolve within a few days — any of these, in a knee with known or suspected cartilage damage, warrants specialist review rather than watchful waiting. Early-stage lesions, where the defect remains shallow and the subchondral bone intact, present the widest range of treatment options; allowing symptoms to become severe narrows that range permanently.

A specialist assessment typically covers clinical examination, weight-bearing X-ray, and MRI. Weight-bearing films reveal compartment-space narrowing that lying-down X-rays underestimate; MRI characterises the cartilage directly. AI-assisted analysis — onMRI™ combines cartilage segmentation with T2 mapping — can define lesion depth and area precisely enough to establish whether a defect still falls within the threshold for less invasive repair. Objective load and gait assessment (MAI Motion®) adds a further dimension: malalignment and abnormal loading patterns are established accelerants of cartilage loss that imaging alone does not always reveal, and addressing them may need to run alongside any restoration procedure.

Lincolnshire Knee, part of the MSK Doctors group, accepts patients without a GP referral, with clinics at Sleaford NG34 and Grantham NG31 — lincolnshireknee.co.uk.

1. [1] Hyaline cartilage — Wikipedia. https://en.wikipedia.org/?curid=1130627 https://en.wikipedia.org/?curid=1130627
2. [2] Increased lesion depth, higher BMI and older age are risk factors for OA during long-term follow-up in patients with osteochondritis dissecans of the knee. (2022). https://doi.org/10.1007/s00402-022-04638-4 https://doi.org/10.1007/s00402-022-04638-4
3. [3] Time Matters: Knee Cartilage Defect Expansion and High-Grade Lesion Formation while Awaiting Autologous Chondrocyte Implantation. (2021). https://doi.org/10.1177/19476035211063866 https://doi.org/10.1177/19476035211063866
4. [4] Meniscal extrusion: risk factors and diagnostic tools to predict early osteoarthritis. (2023). https://doi.org/10.52965/001c.74881 https://doi.org/10.52965/001c.74881
5. [5] Articular cartilage damage — Wikipedia. https://en.wikipedia.org/?curid=19057920 https://en.wikipedia.org/?curid=19057920